J&J Considers Sale, Spin-Off For Ortho-Clinical Diagnostics
This article was originally published in The Gray Sheet
Johnson & Johnson announced plans to evaluate strategic options for its Ortho-Clinical Diagnostics unit during the firm’s medical devices and diagnostics business review.
You may also be interested in...
Device financing dropped more than 40% to $714 million in Q1; Smith & Nephew’s $1.7 billion acquisition of ArthroCare overshadowed acquisitions. Diagnostics companies raised $568 million, a 34% increase over 2013’s final quarter; nonprofits provided assets to diagnostics firms in multiple licensing arrangements.
News Briefs: Medtronic’s CoreValve Approval; J&J Dx Unit Set For Sale; Google’s Glucometer Contact Lens
Medtronic gains FDA approval for its transcather CoreValve system months earlier than predicted. The Carlyle Group makes binding offer for J&J’s Ortho-Clinical Diagnostics business. Google is developing a wireless glucometer embedded within a contact lens. More news briefs.
In Part 3 of our feature, we take a closer look at the first quarterly calls for Abbott and AbbVie after the company split in two, plus the latest on emerging markets from J&J and Novartis.